ClinicalTrials.gg
CompletedNCT06610955Updated Nov 6, 2026

Comparison of Two Different Intensity Exercises on Young Women With Obesity

An interventional study of High intensity interval training and Moderate intensity continuous training in Obesity and Exercise Training, sponsored by Ahi Evran University Education and Research Hospital. Completed at 1 site in Turkey (Türkiye). Open to female participants aged 18 Years to 45 Years. Per ClinicalTrials.gov, last updated 2026-11-06.

Sponsored by Ahi Evran University Education and Research Hospital · Not applicable, Interventional, and Treatment

How we know

Updated Nov 6, 2026Now CompletedFirst site in Turkey (Türkiye)+7 moreGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
40
Allocation
Randomized
Ages
18 Years to 45 Years
Sex
Female
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 353 studies in Obesity with a site in Turkey — 73 open to participants now, 90 under way, 16 of them phase 3. Obesity · Turkey.

Enrollment
141st of 192
40 · median 64
Started
2024
with 37 others
No phase
161 of 353
29 open now
Registered
182nd of 353
by date

Among the 353 studies in Obesity with a site in Turkey, this one is the 141st largest by enrollment of the 192 interventional ones that give a count, is one of 38 that started in 2024, is one of 161 with no phase, and was the 182nd registered.

Obesity

11,564 studies on the registry are indexed under Obesity; 2,063 are open to participants now.

Browse Obesity studies →

Open to participants now

73 of the 353 studies in Obesity with a site in Turkey are open now. Recruiting first, the newest first:

68 more — sign in →

All 73 open studies →

A study can be open while its sites in Turkey have not opened yet or have stopped. Only those recruiting at a site in Turkey →

Who these studies take

Of the 1,352 Obesity studies recruiting now, 382 (28%) set no upper age limit and 867 (64%) stop at 75 or younger; 169 take children under 18; 491 take healthy volunteers.

This study: 18 Years to 45 Years · female · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 353 studies in Obesity with a site in Turkey, or all of them as a file.
02

Study summary

Obesity is one of the most common preventable public health problems. Diet regulation and exercise practices are the most commonly used methods in reducing fat tissue. There are various exercise methods applied in the weight loss process and the effects of different types of exercise modalities on body fat rate and metabolic status.The aim of our study is to determine the effects of high intensity interval exercise and moderate intensity continuous exercise on serum , omentin, leptin and adiponectin levels, anthropometric measurements used in obesity follow up, body fat percentage and their effects on the quality of sleep and life of women with obesity.

Read the detailed description

Female participants aged 18-45 with a body mass index of 30-40 kg/m² who met the inclusion and exclusion criteria were randomized into two groups using a simple randomization method using a computer. One group will perform high intensity interval exercise with an Ergoline bicycle ergometry device for 45 minutes a day, 5 days a week for 8 weeks, while the other group will perform moderate intensity continuous exercise on the same device. Peripheral venous blood samples will be taken from all participants at the beginning and end of the study, anthropometric measurements used in obesity monitoring of all participants will be taken and noted, and participants will be asked to fill out questionnaires containing questions about their sleep and quality of life. The analysis of the blood samples taken will be carried out in the Biochemistry Laboratory of Kırşehir Ahi Evran University. The data of our study will be analyzed with the statistical package program SPSS version 23.0.

03

Conditions studied

  • Obesity
  • Exercise Training

Browse trials for

Keywords

  • Obesity
  • Exercise Training
  • Adipokines
04

Who can participate

Ages eligible
18 Years to 45 Years
Sexes eligible
Female
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Female between the age of 18-45
  • 30-40 kg/m²
  • Primary obesity

Exclusion criteria

Exclusion Criteria:

  • Patients with cardiac, pulmonary, endocrinological, rheumatological diseases
  • Pregnancy and breastfeeding
  • Using antipsychotics, antidepressants (lithium, tricyclic antidepressants, mono amino oxidase inhibitors), anticonvulsants, antihistamines, , antidiabetics (sulfonylureas, insulins, glitazones) sex hormones
  • Using oral
  • History of bariatric surgery
  • Patients using obesity medication in the last 6 months, complying with a regular diet and exercise program
  • Presence of orthopedic or neurological problems that difficulty of participate aerobic exercise training
Terms in these criteria, in plain language(3)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

BMI (body mass index)

Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.

What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.

Corticosteroids (steroids)

Anti-inflammatory medicines such as prednisone, prednisolone and dexamethasone — not the anabolic steroids used for muscle.

Studies differ in what they allow: check which steroid medicines, routes (tablets, injections, creams, inhalers, eye drops) and doses this study accepts.

Contraception

Ways of preventing pregnancy. “Highly effective” methods fail less than 1% of the time a year when used correctly — for example an IUD or an implant.

Criteria usually say which methods count and how long to keep using them after the last dose, sometimes for male participants too. Some studies accept a partner’s vasectomy if it was confirmed successful and that person is the participant’s only sexual partner.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Investigator, Outcomes assessor)
Enrollment
40 participants (actual)

Study arms

  • Active comparator
    High intensity interval training exercise group

    After a 10 minutes warm up exercise, participants will exercise with a bicycle ergometry device at 80% of their maximum heart rate for 4 minutes, and the active recovery period will be 3 minutes (4x4 minutes). During the recovery period, the participant will exercise with the Ergoline bicycle ergometry system for 4 sets at 60% of their maximum heart rate for 3 minutes. A total of 45 minutes exercise session will be completed with a 10 minutes cool down exercise. Exercise will be done 5 days a week for a total of 8 weeks. In the first 4 weeks, exercise will be done at 80% intensity, and in the following weeks, the exercise intensity will be increased by 5% each week, respectively, to 85%, 90%, 95%, and 100% in the last week.

    Other: High intensity interval training

  • Active comparator
    Moderate intensity continuous exercise group

    Following a 10 minutes warm up exercise, participants will exercise continuously for 30 minutes at 65% of their maximum heart rate with the Ergoline bicycle ergometry system. A 5 minutes cool down exercise will end the 45 minutes exercise session. The exercise duration is 5 days a week for a total of 8 weeks.

    Other: Moderate intensity continuous training

Interventions

  • OtherHigh intensity interval training

    After a 10 minutes warm up exercise, participants will exercise with a bicycle ergometry device at 80% of their maximum heart rate for 4 minutes, and the active recovery period will be 3 minutes (4x4 minutes). During the recovery period, the participant will exercise with the Ergoline bicycle ergometry system for 4 sets at 60% of their maximum heart rate for 3 minutes. A total of 45 minutes exercise session will be completed with a 10 minutes cool down exercise. Exercise will be done 5 days a week for a total of 8 weeks. In the first 4 weeks, exercise will be done at 80% intensity, and in the following weeks, the exercise intensity will be increased by 5% each week, respectively, to 85%, 90%, 95%, and 100% in the last week.

  • OtherModerate intensity continuous training

    Following a 10 minutes warm up exercise, participants will exercise continuously for 30 minutes at 65% of their maximum heart rate with the Ergoline bicycle ergometry system. A 5 minutes cool down exercise will end the 45 minutes exercise session. The exercise duration is 5 days a week for a total of 8 weeks.

06

What researchers measure

Primary outcomes

  1. Serum adipokine levels

    This study aimed to investigate the effects of high intensity interval exercise and moderate intensity continuous exercise on serum adiponectin, leptin and omentin levels in young women with obesity.

    Time frame: 8 weeks

Secondary outcomes

  1. Anthropometric measurement

    waist and hip circumference measurements

    Time frame: 8 weeks

  2. Percentage of body fat

    skinfold thickness will measure with skinfold caliper

    Time frame: 8 weeks

  3. The impact of weight on quality of life

    The impact of weight on quality of life will describe with The Impact of Weight on Quality of Life-Lite index

    Time frame: 8 weeks

  4. Quality of sleep

    Sleep quality will describe Pittsburgh sleep quality index

    Time frame: 8 weeks

07

Study locations

1 site
08

References and documents

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedDate before it movedWhere the date was before it movedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Oct 2024 to primary completion in Oct 2025, 12 months.

Of 3,697 non-industry interventional studies with no phase under Obesity, half reached primary completion within 23 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 43. This study's 12 months is below that.

Counting every sponsor, half of 3,861 studies reached it within 22 months; a quarter within 9 and three quarters within 42.

Since we started tracking on Sep 25, 2026, the dates moved once, on Nov 6, 2026: primary completion Jul 2025 → Oct 2025 and completion Jul 2025 → Dec 2025.

Earlier changes are on the record history on ClinicalTrials.gov ↗

How these figures are worked out, and which studies are left out of them.

Registered
Sep 15, 2024
First posted
Sep 24, 2024
StartActual
Oct 8, 2024
Primary completionActual
Oct 8, 2025was Jul 2025
CompletionActual
Dec 31, 2025was Jul 2025
Last update
Nov 6, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Status
Recruiting→Completed
changed Nov 6, 2026
Sites
1 site added, 1 site removed — first site in Turkey (Türkiye); no longer in Turkey
Show site
  • Kırşehir Ahi Evran Üniversitesi · Kırşehir, Turkey (Türkiye)
Show 1 removed
  • Kırşehir Ahi Evran Üniversitesi · Kırşehir, Turkey
Nov 6, 2026
Start date
Oct 18, 2024→Oct 8, 2024
Nov 6, 2026
Primary completion
Jul 2025→Oct 8, 2025 (actual)
Nov 6, 2026
Study completion
Jul 2025→Dec 31, 2025 (actual)
Nov 6, 2026
Show all 1 update
  1. Nov 6, 2026
    Recruiting→Completed
    1 site added, 1 site removed — first site in Turkey (Türkiye); no longer in Turkey
    Show site
    • Kırşehir Ahi Evran Üniversitesi · Kırşehir, Turkey (Türkiye)
    Show 1 removed
    • Kırşehir Ahi Evran Üniversitesi · Kırşehir, Turkey
    Start date Oct 18, 2024→Oct 8, 2024
    Primary completion Jul 2025→Oct 8, 2025 (now actual)
    Study completion Jul 2025→Dec 31, 2025 (now actual)
    + 2 other changes: contact details and index terms

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT06610955
Lead sponsor
Ahi Evran University Education and Research Hospital
Responsible party
Figen Tuncay (Professor, Ahi Evran University Education and Research Hospital) — Principal investigator
First posted
Sep 24, 2024
Start date
Oct 8, 2024
Primary completion
Oct 8, 2025
Completion
Dec 31, 2025
Last update
Nov 6, 2026

Study contacts

Figen Tuncay, Professor
principal investigator · Ahi Evran Univeristy
Elif Kapaklı, RA
study chair · Kirsehir Ahi Evran Universitesi
Gamze Turna Saltoğlu, Ass. Prof.
study chair · Kirsehir Ahi Evran Universitesi
Başak Çiğdem Karaçay, Assoc. Prof.
study chair · Kirsehir Ahi Evran Universitesi
Nazife Kapan, Ass. Prof.
study chair · Kirsehir Ahi Evran Universitesi
Başak Kavalcı Kol, Ass. Prof.
study chair · Kirsehir Ahi Evran Universitesi
Merve Fırat, Ass. Prof.
study chair · Kirsehir Ahi Evran Universitesi

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Feb 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion